Wednesday, November 19, 2014 2:19:47 PM
See:
http://en.wikipedia.org/wiki/Internal_Revenue_Code_section_355
http://www.law.cornell.edu/uscode/text/26/355
http://www.irs.gov/pub/irs-irbs/irb13-28.pdf#page=11
http://www.stblaw.com/docs/default-source/cold-fusion-existing-content/publications/pub1624.pdf?sfvrsn=2
There's also an application to FINRA that must be made, and I have experience with the FINRA approval process -- we will have no problem obtaining approval from FINRA as soon as Bill Hodson files the required annual list of officers and directors with the Nevada Secretary of State.
The FINRA requirement is for a pro-rata stock dividend, whereas IRC Section 355 seems to allow dividends that are not pro-rata -- it is my understanding that the latter is only applicable to privately-held companies. It makes sense that FINRA expects pro-rata dividends for spin-outs, or the investors who buy shares via public markets could easily be diluted into nothing through a spin-out.
To conclude a pro-rata stock dividend with FINRA approval Bill Hodson must finish the claw-back of the improperly-issued shares that Shelly Singhal instructed Wen Peng to issue to his affiliates, including his wife. Everything that has NOT happened that should have happened by now and that I was promised in January seems to revolve around this share claw-back. Shelly objects to it for some reason, but he also objects to the spin-out on the grounds that it will create a tax liability. It clearly won't create a tax liability for anybody, it is fully compliant with the letter and the spirit of IRC Section 355.
On the business development and capital formation side, I have both customers and investors who are merely waiting for Shelly and Bill. As soon as the conflict is resolved with the help of their attorney, I'll be moving everything forward substantially and will provide regular updates -- if the final JOBS Act Rules contain flaws that impose large financial burdens on startups then I will be filing a registration statement for Homeland Forensics, Inc. and/or Public Startup Company, Inc. rather than relying on the JOBS Act for crowdfunding next year.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM